#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cushing's syndrome Aspergillus infection Congenital leptin deficiency Mucopolysaccharidosis I Small intestine neuroendocrine tumour Marginal zone lymphoma Huntington's disease Heavy menstrual bleeding Neuroblastoma recurrent Liver abscess Cutaneous lupus erythematosus Rheumatoid arthritis Alveolar proteinosis Hepato-lenticular degeneration Extra-osseous Ewing's sarcoma More trials…

    Learn about Rare Diseases

    Ocular melanoma Progressive supranuclear palsy – Life with Disease Tuberous sclerosis complex – Life with Disease Osteosarcoma – Diagnostics Prader-Willi syndrome Primary immunodeficiency syndrome – Life with Disease Skin angiosarcoma – Life with Disease Rhabdomyosarcoma recurrent – Treatment Langerhans cell sarcoma – Trials in Disease Factor IX deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Damoctocog Alfa Pegol Sitravatinib Malate Vudalimab 204-NETU Gozetotide Alf-18 Petrelintide TEV-53408 Regn7075 Vindesine Sulfate Arachis Hypogaea Extract Tenofovir Disoproxil Vosoritide Anhydrous Caffeine Foscarnet Thiamine HSP-CAR30 Amphotericin B INSULIN DEGLUDEC Adrc001 AGALSIDASE BETA More therapies…

    Learn about Your Condition

    Triple positive breast cancer Osteomyelitis Body mass index increased Hypocalcaemia Urea cycle disorder Shprintzen-Goldberg syndrome Primary amyloidosis Myotonic dystrophy Ischaemic skin ulcer Neuroblastoma Dermatomyositis Sjogren's syndrome Optic ischaemic neuropathy Mantle cell lymphoma stage III Hepatic cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • Title: Evaluation of lorazepam, pregabalin, and olanzapine in treating agitated behavior in dementia patients who did not respond to standard treatments

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia
    Investigated Drugs:
    • Lorazepam
    • Pregabalin
    • Fluoxetine Hydrochloride
    The Netherlands

  • Study on Preventing Atrial Fibrillation After Heart Surgery Using Landiolol Hydrochloride in Patients with Normal Heart Function

    Recruiting

    3 1 1
    Investigated Diseases:
    • Ejection fraction normal
    • Sinus rhythm
    Investigated Drugs:
    • Landiolol Hydrochloride
    Austria

  • Study on Triamcinolone Acetonide and Pulsed Radiofrequency for Chronic Shoulder Pain in Adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Arthralgia
    Investigated Drugs:
    • Triamcinolone Acetonide
    Spain

  • Study on Reducing Bleeding Risk in Fibroid Surgery Using Misoprostol for Patients Undergoing Myomectomy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Uterine leiomyoma
    Investigated Drugs:
    • Misoprostol
    • Placebo
    France

  • Study on Immunotherapy with HSP-CAR19M and Drug Combination for Adults with B-cell Non-Hodgkin Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • Follicular lymphoma
    • Mantle cell lymphoma
    Investigated Drugs:
    • HSP-CAR19M
    • Bendamustine Hydrochloride
    • Cyclophosphamide Monohydrate
    Spain

  • Study on Psilocybin for Relieving Chronic Neuropathic Pain in Patients with Chemotherapy-Induced Peripheral Neuropathy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neuralgia
    • Neuropathy peripheral
    Investigated Drugs:
    • Oxazepam
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    The Netherlands
Previous Page
1 2 3 4 5 6 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!